儿童肿瘤放疗剂量相关远期并发症研究进展

doi:10.3760/cma.j.cn113030-20200628-00325

Abstract
Figure/Table
References()
Related Citation (1)
Read Tracking
Download Tracking

Download: PDF (0 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS) Supporting Info

Abstract Children with pediatric tumors have better prognosis and longer survival than adults, suggesting that attention should be paid to the long-term complications induced by radiotherapy. In this article, the data from more than 40 clinical studies of pediatric tumor radiotherapy published in the recent decade were retrospectively analyzed. Long-term complications of nervous system, cardio-cerebrovascular system, respiratory system, endocrine system, urinary system, reproductive system, skeletal development, long-term secondary tumors were considered and the corresponding radiation dose-volume parameters were summarized, aiming to guide radiation oncology physicians and physicists to optimize radiotherapy plans for children with pediatric tumors.

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	Qiu Wenlong
	Shi Pengyue
	Wang Jingfu
	Zhu Jian
	Yu Jinming

Key words： Pediatric neoplasm/radiotherapy Long-term complication

Received: 28 June 2020

Fund:Shandong Provincial Natural Science Foundation (ZR2020LZL001);Foundation of Taishan Scholars of Shandong Province (tsqn201909140);Academic Promotion Program of Shandong First Medical University (2020RC003);National Key Research and Development Program (2018YFC1313201)

Corresponding Authors: Yu Jinming, Email:sdyujinming@163.com

Cite this article:

Qiu Wenlong,Shi Pengyue,Wang Jingfu et al. Research progress on dosimetry-related long-term complications of pediatric cancer radiotherapy[J]. Chinese Journal of Radiation Oncology, 2021, 30(4): 413-418.

URL:

http://journal12.magtechjournal.com/Jweb_fszlx/EN/10.3760/cma.j.cn113030-20200628-00325 OR http://journal12.magtechjournal.com/Jweb_fszlx/EN/Y2021/V30/I4/413

[1] Howlader N, Noone AM, Krapcho M, et al. SEER cancer statistics review, 1975-2017[M/OL]. Bethesda, MD:National Cancer Institute, 2020. https://seer.cancer.gov/csr/1975_2017/.
[2] Hudson MM, Ness KK, Gurney JG, et al. Clinical ascertainment of health outcomes among adults treated for childhood cancer[J]. JAMA, 2013, 309(22):2371-2381. DOI:10.1001/jama.2013.6296.
[3] Whelan KF, Stratton K, Kawashima T, et al. Ocular late effects in childhood and adolescent cancer survivors:a report from the childhood cancer survivor study[J]. Pediatr Blood Cancer, 2010, 54(1):103-109. DOI:10.1002/pbc.22277.
[4] Whelan K, Stratton K, Kawashima T, et al. Auditory complications in childhood cancer survivors:a report from the childhood cancer survivor study[J]. Pediatr Blood Cancer, 2011, 57(1):126-134. DOI:10.1002/pbc.23025.
[5] Wells EM, Ullrich NJ, Seidel K, et al. Longitudinal assessment of late-onset neurologic conditions in survivors of childhood central nervous system tumors:a childhood cancer survivor study report[J]. Neuro Oncol, 2018, 20(1):132-142. DOI:10.1093/neuonc/nox148.
[6] Brinkman TM, Krasin MJ, Liu W, et al. Long-term neurocognitive functioning and social attainment in adult survivors of pediatric CNS tumors:results from the St Jude lifetime cohort study[J]. J Clin Oncol, 2016, 34(12):1358-1367. DOI:10.1200/JCO.2015.62.2589.
[7] Merchant TE, Conklin HM, Wu S, et al. Late effects of conformal radiation therapy for pediatric patients with low-grade glioma:prospective evaluation of cognitive, endocrine, and hearing deficits[J]. J Clin Oncol, 2009, 27(22):3691-3697. DOI:10.1200/JCO.2008.21.2738.
[8] Armstrong GT, Jain N, Liu W, et al. Region-specific radiotherapy and neuropsychological outcomes in adult survivors of childhood CNS malignancies[J]. Neuro Oncol, 2010, 12(11):1173-1186. DOI:10.1093/neuonc/noq104.
[9] Yock TI, Bhat S, Szymonifka J, et al. Quality of life outcomes in proton and photon treated pediatric brain tumor survivors[J]. Radiother Oncol, 2014, 113(1):89-94. DOI:10.1016/j.radonc.2014.08.017.
[10] Kahalley LS, Ris MD, Grosshans DR, et al. Comparing intelligence quotient change after treatment with proton versus photon radiation therapy for pediatric brain tumors[J]. J Clin Oncol, 2016, 34(10):1043-1049. DOI:10.1200/JCO.2015.62.1383.
[11] Brinkman TM, Zhang N, Recklitis CJ, et al. Suicide ideation and associated mortality in adult survivors of childhood cancer[J]. Cancer, 2014, 120(2):271-277. DOI:10.1002/cncr.28385.
[12] Gunnes MW, Lie RT, Bjorge T, et al. Suicide and violent deaths in survivors of cancer in childhood, adolescence and young adulthood-a national cohort study[J]. Int J Cancer, 2017, 140(3):575-580. DOI:10.1002/ijc.30474.
[13] Zureick AH, Evans CL, Niemierko A, et al. Left hippocampal dosimetry correlates with visual and verbal memory outcomes in survivors of pediatric brain tumors[J]. Cancer, 2018, 124(10):2238-2245. DOI:10.1002/cncr.31143.
[14] Gondi V, Pugh SL, Tome WA, et al. Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933):a phase Ⅱ multi-institutional trial[J]. J Clin Oncol, 2014, 32(34):3810-3816. DOI:10.1200/JCO.2014.57.2909.
[15] Gondi V, Hermann BP, Mehta MP, et al. Hippocampal dosimetry predicts neurocognitive function impairment after fractionated stereotactic radiotherapy for benign or low-grade adult brain tumors[J]. Int J Radiat Oncol Biol Phys, 2012, 83(4):e487-493. DOI:10.1016/j.ijrobp.2012.11.031.
[16] Marks LB, Yorke ED, Jackson A, et al. Use of normal tissue complication probability models in the clinic[J]. Int J Radiat Oncol Biol Phys, 2010, 76(3 suppl):S10-19. DOI:10.1016/j.ijrobp.2009.07.1754.
[17] Mulrooney DA, Yeazel MW, Kawashima T, et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer:retrospective analysis of the childhood cancer survivor study cohort[J]. BMJ, 2009, 339:b4606. DOI:10.1136/bmj.b4606.
[18] Bates;JE, Howell RM, Liu Q, et al. Therapy-related cardiac risk in childhood cancer survivors:an analysis of the childhood cancer survivor study[J]. J Clin Oncol, 2019, 37(13):1090-1101. DOI:10.1200/JCO.18.01764.
[19] El-Fayech C, Haddy N, Allodji RS, et al. Cerebrovascular diseases in childhood cancer survivors:role of the radiation dose to willis circle arteries[J]. Int J Radiat Oncol Biol Phys, 2017, 97(2):278-286. DOI:10.1016/j.ijrobp.2016.10.015.
[20] Venkatramani R, Kamath S, Wong K, et al. Pulmonary outcomes in patients with Hodgkin lymphoma treated with involved field radiation[J]. Pediatr Blood Cancer, 2014, 61(7):1277-1281. DOI:10.1002/pbc.24969.
[21] Lewis GD, Agrusa JE, Teh BS, et al. Radiation pneumonitis in pediatric Hodgkin lymphoma patients receiving radiation therapy to the chest[J]. Pract Radiat Oncol, 2018, 8(5):e364-e368. DOI:10.1016/j.prro.2018.01.007.
[22] Chemaitilly W, Li Z, Huang S, et al. Anterior hypopituitarism in adult survivors of childhood cancers treated with cranial radiotherapy:a report from the St Jude lifetime cohort study[J]. J Clin Oncol, 2015, 33(5):492-500. DOI:10.1200/JCO.2014.56.7933.
[23] Chemaitilly W, Sklar CA. Childhood cancer treatments and associated endocrine late effects:a concise guide for the pediatric endocrinologist[J]. Horm Res Paediatr, 2019, 91(2):74-82. DOI:10.1159/000493943.
[24] Eaton BR, Esiashvili N, Kim S, et al. Endocrine outcomes with proton and photon radiotherapy for standard risk medulloblastoma[J]. Neuro Oncol, 2016, 18(6):881-887. DOI:10.1093/neuonc/nov302.
[25] De Vathaire F, El-Fayech C, Ben Ayed FF, et al. Radiation dose to the pancreas and risk of diabetes mellitus in childhood cancer survivors:a retrospective cohort study[J]. Lancet Oncol, 2012, 13(10):1002-1010. DOI:10.1016/S1470-2045(12)70323-6.
[26] Jouglar E, Wagner A, Delpon G, et al. Can we spare the pancreas and other abdominal organs at risk? A comparison of conformal radiotherapy, helical tomotherapy and proton beam therapy in pediatric irradiation[J]. PLoS One, 2016, 11(10):e0164643. DOI:10.1371/journal.pone.0164643.
[27] Jones DP, Spunt SL, Green D, et al. Renal late effects in patients treated for cancer in childhood:a report from the children's oncology group[J]. Pediatr Blood Cancer, 2008, 51(6):724-731. DOI:10.1002/pbc.21695.
[28] Ritchey M, Ferrer F, Shearer P, et al. Late effects on the urinary bladder in patients treated for cancer in childhood:a report from the children's oncology group[J]. Pediatr Blood Cancer, 2009, 52(4):439-446. DOI:10.1002/pbc.21826.
[29] Signorello LB, Cohen SS, Bosetti C, et al. Female survivors of childhood cancer:preterm birth and low birth weight among their children[J]. J Natl Cancer Inst, 2006, 98(20):1453-1461. DOI:10.1093/jnci/djj394.
[30] Kenney LB, Cohen LE, Shnorhavorian M, et al. Male reproductive health after childhood, adolescent, and young adult cancers:a report from the children's oncology group[J]. J Clin Oncol, 2012, 30(27):3408-3416. DOI:10.1200/JCO.2011.38.6938.
[31] Kenney LB, Antal Z, Ginsberg JP, et al. Improving male reproductive health after childhood, adolescent, and young adult cancer:progress and future directions for survivorship research[J]. J Clin Oncol, 2018, 36(21):2160-2168. DOI:10.1200/JCO.2017.76.3839.
[32] Rao AD, Ladra M, Dunn E, et al. A road map for important centers of growth in the pediatric skeleton to consider during radiation therapy and associated clinical correlates of radiation-induced growth toxicity[J]. Int J Radiat Oncol Biol Phys, 2019, 103(3):669-679. DOI:10.1016/j.ijrobp.2018.10.026.
[33] Dörr W, Kallfels S, Herrmann T. Late bone and soft tissue sequelae of childhood radiotherapy. Relevance of treatment age and radiation dose in 146 children treated between 1970 and 1997[J]. Strahlenther Onkol, 2013, 189(7):529-534. DOI:10.1007/s00066-013-0361-y.
[34] Lockney NA, Friedman DN, Wexler LH, et al. Late toxicities of intensity-modulated radiation therapy for head and neck rhabdomyosarcoma[J]. Pediatr Blood Cancer, 2016, 63(9):1608-1614. DOI:10.1002/pbc.26061.
[35] Friedman DL, Whitton J, Leisenring W, et al. Subsequent neoplasms in 5-year survivors of childhood cancer:the childhood cancer survivor study[J]. J Natl Cancer Inst, 2010, 102(14):1083-1095. DOI:10.1093/jnci/djq238.
[36] Armstrong GT, Liu Q, Yasui Y, et al. Late mortality among 5-year survivors of childhood cancer:a summary from the childhood cancer survivor study[J]. J Clin Oncol, 2009, 27(14):2328-2338. DOI:10.1200/JCO.2008.21.1425.
[37] Bhatti P, Veiga LH, Ronckers CM, et al. Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study:an update from the childhood cancer survivor study[J]. Radiat Res, 2010, 174(6):741-752. DOI:10.1667/RR2240.1.
[38] Lee CY, Chen YW, Lee YY, et al. Irradiation-induced secondary tumors following pediatric central nervous system tumors:experiences of a single institute in taiwan (1975-2013)[J]. Int J Radiat Oncol Biol Phys, 2018, 101(5):1243-1252. DOI:10.1016/j.ijrobp.2018.04.032.
[39] Armstrong GT, Liu W, Leisenring W, et al. Occurrence of multiple subsequent neoplasms in long-term survivors of childhood cancer:a report from the childhood cancer survivor study[J]. J Clin Oncol, 2011, 29(22):3056-3064. DOI:10.1200/JCO.2011.34.6585.
[40] Chung CS, Yock TI, Nelson K, et al. Incidence of second malignancies among patients treated with proton versus photon radiation[J]. Int J Radiat Oncol Biol Phys, 2013, 87(1):46-52. DOI:10.1016/j.ijrobp.2013.04.030.
[41] Kaste SC, Goodman P, Leisenring W, et al. Impact of radiation and chemotherapy on risk of dental abnormalities:a report from the childhood cancer survivor study[J]. Cancer, 2009, 115(24):5817-5827. DOI:10.1002/cncr.24670.
[42] Weil BR, Madenci AL, Liu Q, et al. Late infection-related mortality in asplenic survivors of childhood cancer:a report from the childhood cancer survivor study[J]. J Clin Oncol, 2018, 36(16):1571-1578. DOI:10.1200/JCO.2017.76.1643.
[43] Weber DC, Habrand JL, Hoppe BS, et al. Proton therapy for pediatric malignancies:fact, figures and costs. A joint consensus statement from the pediatric subcommittee of PTCOG, PROS and EPTN[J]. Radiother Oncol, 2018, 128(1):44-55. DOI:10.1016/j.radonc.2018.05.020.
[44] Journy N, Indelicato DJ, Withrow DR, et al. Patterns of proton therapy use in pediatric cancer management in 2016:an international survey[J]. Radiother Oncol, 2019, 132:155-161. DOI:10.1016/j.radonc.2018.10.022.